ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,206 | +3051.4% | 4,490 | +2394.4% | 0.00% | – |
| Q2 2023 | $70 | +4.5% | 180 | 0.0% | 0.00% | – |
| Q1 2023 | $67 | -88.5% | 180 | -88.3% | 0.00% | -100.0% |
| Q4 2022 | $581 | -99.9% | 1,536 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $542,000 | +642.5% | 1,536 | +691.8% | 0.00% | – |
| Q2 2022 | $73,000 | +19.7% | 194 | 0.0% | 0.00% | – |
| Q1 2022 | $61,000 | -9.0% | 194 | 0.0% | 0.00% | – |
| Q4 2021 | $67,000 | -41.2% | 194 | -48.8% | 0.00% | – |
| Q3 2021 | $114,000 | 0.0% | 379 | 0.0% | 0.00% | – |
| Q2 2021 | $114,000 | +9.6% | 379 | 0.0% | 0.00% | – |
| Q1 2021 | $104,000 | -4.6% | 379 | +1.3% | 0.00% | – |
| Q4 2020 | $109,000 | +11.2% | 374 | 0.0% | 0.00% | – |
| Q3 2020 | $98,000 | -92.1% | 374 | -96.6% | 0.00% | -100.0% |
| Q3 2019 | $1,237,000 | -21.0% | 10,859 | -1.8% | 0.00% | -33.3% |
| Q2 2019 | $1,565,000 | +15.5% | 11,059 | +1.8% | 0.00% | +50.0% |
| Q1 2019 | $1,355,000 | +29.9% | 10,859 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,043,000 | – | 10,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |